<DOC>
	<DOCNO>NCT00345046</DOCNO>
	<brief_summary>Generic prednisolone acetate 1 % le effective Pred Forte 1 % Econopred Plus 1 % .</brief_summary>
	<brief_title>A Comparison Three Different Formulations Prednisolone Acetate 1 %</brief_title>
	<detailed_description>Overall Study Design : Structure : This randomize , double-masked prospective study . The study medication mask randomized outpatient pharmacy Indiana University Hospital . Duration : Treatment duration : The duration subject 's participation 2 month surgery . One hundred two subject enrol twelve-month time span . Controls : Examiner , staff , subject mask . Parallel group comparison . Dosage/Dose Regimen/Instructions : Subjects schedule glaucoma and/or cataract surgery recruit . Subjects may currently steroid ophthalmic non-steroidal anti-inflammatory ( NSAID ) therapy minimum 6 week prior surgery . Subjects randomize receive dose Pred Forte 1 % ( Allergan ) , Econopred Plus 1 % ( Alcon ) prednisolone acetate 1 % ( Falcon ) four time day start immediately finish surgery two week , twice day two week . After 1 month therapy subject stop continue steroid treatment base clinical finding . No subconjunctival steroid ointment use intra-operatively post-operatively . The eye drop instill per label instruction .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Be willing able provide write informed consent . Be able willing follow instruction use study medication likely complete entire course study . Be male female race least 18 year age . Have visually significant cataract medically uncontrolled glaucoma elect undergo surgery . Contraindication use corticosteroid . Ocular disease glaucoma ocular hypertension would interfere study parameter ( : uveitis , ocular infection , severe dry eye ) . Subjects mild chronic blepharitis , agerelated macular degeneration background diabetic retinopathy may enrol discretion investigator . Laser intraocular surgery within past three month . Require use ocular NSAID systemic steroid . Have know allergy sensitivity study medication component Have corneal abnormality would interfere ability obtain adequate laser flare measurement . Be concurrently enrol investigational drug device study participation within last 30 day investigational drug device study . Be pregnant , nursing , plan pregnancy , childbearing potential use reliable form contraception ( woman consider childbearing potential unless postmenopausal , uterus and/or ovary remove , bilateral tubal ligation ) . Have situation condition investigator 's opinion may put subject significant risk , may confound study result , may interfere significantly participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Cataract</keyword>
</DOC>